Though the approval of Tremfya for psoriasis and psoriatic arthritis indications in kids will contribute to sales growth, the key to Tremfya’s growth is its approval for inflammatory bowel ...

NICE has recommended broadening NHS use of Novartis' IL-17 inhibitor Cosentyx to include children aged six to 17 with severe plaque psoriasis. The cost-effectiveness agency says in draft guidance ...

Knowing which kind of psoriasis you have helps you and your doctor make a treatment plan. Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease.

Inflammation is thought to play a role in the development of psoriasis. In some cases, treating the underlying inflammation may help manage both psoriasis and the risk of related inflammatory ...